These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

642 related items for PubMed ID: 10863062

  • 1. A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study).
    Choy H, Devore RF, Hande KR, Porter LL, Rosenblatt P, Yunus F, Schlabach L, Smith C, Shyr Y, Johnson DH.
    Int J Radiat Oncol Biol Phys; 2000 Jul 01; 47(4):931-7. PubMed ID: 10863062
    [Abstract] [Full Text] [Related]

  • 2. Preliminary analysis of a phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancer.
    Choy H, DeVore RF, Hande KR, Porter LL, Rosenblatt P, Yunus F, Schlabach L, Smith C, Shyr Y, LaPorte K, Johnson DH.
    Semin Oncol; 1997 Aug 01; 24(4 Suppl 12):S12-21-S12-26. PubMed ID: 9331115
    [Abstract] [Full Text] [Related]

  • 3. A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer (NSCLC).
    Jain AK, Hughes RS, Sandler AB, Dowlati A, Schwartzberg LS, Dobbs T, Schlabach L, Wu J, Muldowney NJ, Choy H.
    J Thorac Oncol; 2009 Jun 01; 4(6):722-7. PubMed ID: 19404213
    [Abstract] [Full Text] [Related]

  • 4. Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial.
    Lau D, Leigh B, Gandara D, Edelman M, Morgan R, Israel V, Lara P, Wilder R, Ryu J, Doroshow J.
    J Clin Oncol; 2001 Jan 15; 19(2):442-7. PubMed ID: 11208837
    [Abstract] [Full Text] [Related]

  • 5. Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer.
    Choy H, Akerley W, Safran H, Graziano S, Chung C, Williams T, Cole B, Kennedy T.
    J Clin Oncol; 1998 Oct 15; 16(10):3316-22. PubMed ID: 9779707
    [Abstract] [Full Text] [Related]

  • 6. Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trial.
    Choy H, DeVore RF, Hande KR, Porter LL, Rosenblatt PA, Slovis B, Laporte K, Shyr Y, Johnson DH.
    Lung Cancer; 2001 Dec 15; 34(3):441-9. PubMed ID: 11714542
    [Abstract] [Full Text] [Related]

  • 7. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.
    Komaki R, Scott CB, Sause WT, Johnson DH, Taylor SG, Lee JS, Emami B, Byhardt RW, Curran WJ, Dar AR, Cox JD.
    Int J Radiat Oncol Biol Phys; 1997 Oct 01; 39(3):537-44. PubMed ID: 9336129
    [Abstract] [Full Text] [Related]

  • 8. Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.
    Hirsh V, Soulieres D, Duclos M, Faria S, Del Vecchio P, Ofiara L, Ayoub JP, Charpentier D, Gruber J, Portelance L, Souhami L.
    J Thorac Oncol; 2007 Oct 01; 2(10):927-32. PubMed ID: 17909355
    [Abstract] [Full Text] [Related]

  • 9. Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer.
    Choy H, Safran H, Akerley W, Graziano SL, Bogart JA, Cole BF.
    Clin Cancer Res; 1998 Aug 01; 4(8):1931-6. PubMed ID: 9717821
    [Abstract] [Full Text] [Related]

  • 10. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial.
    Rosenman JG, Halle JS, Socinski MA, Deschesne K, Moore DT, Johnson H, Fraser R, Morris DE.
    Int J Radiat Oncol Biol Phys; 2002 Oct 01; 54(2):348-56. PubMed ID: 12243807
    [Abstract] [Full Text] [Related]

  • 11. Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small cell lung cancer.
    Stinchcombe TE, Morris DE, Lee CB, Moore DT, Hayes DN, Halle JS, Rivera MP, Rosenman JG, Socinski MA.
    J Thorac Oncol; 2008 Mar 01; 3(3):250-7. PubMed ID: 18317067
    [Abstract] [Full Text] [Related]

  • 12. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
    Langer CJ, Movsas B, Hudes R, Schol J, Keenan E, Kilpatrick D, Yeung C, Curran W.
    Semin Oncol; 1997 Aug 01; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
    [Abstract] [Full Text] [Related]

  • 13. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, Bogart J, Hu C, Forster K, Magliocco A, Kavadi V, Garces YI, Narayan S, Iyengar P, Robinson C, Wynn RB, Koprowski C, Meng J, Beitler J, Gaur R, Curran W, Choy H.
    Lancet Oncol; 2015 Feb 01; 16(2):187-99. PubMed ID: 25601342
    [Abstract] [Full Text] [Related]

  • 14. Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer.
    Ratanatharathorn V, Lorvidhaya V, Maoleekoonpairoj S, Phromratanapongse P, Sirilerttrakul S, Kraipiboon P, Cheirsilpa A, Tangkaratt S, Srimuninnimit V, Pattaranutaporn P.
    Lung Cancer; 2001 Feb 01; 31(2-3):257-65. PubMed ID: 11165405
    [Abstract] [Full Text] [Related]

  • 15. Induction carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal thoracic radiation therapy in unresectable stage IIIA/B nonsmall cell lung carcinoma: a modified Phase I trial.
    Socinski MA, Rosenman JG, Schell MJ, Halle J, Russo S, Rivera MP, Clark J, Limentani S, Fraser R, Mitchell W, Detterbeck FC.
    Cancer; 2000 Aug 01; 89(3):534-42. PubMed ID: 10931452
    [Abstract] [Full Text] [Related]

  • 16. Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma: a modified phase I/II trial.
    Socinski MA, Rosenman JG, Halle J, Schell MJ, Lin Y, Russo S, Rivera MP, Clark J, Limentani S, Fraser R, Mitchell W, Detterbeck FC.
    Cancer; 2001 Sep 01; 92(5):1213-23. PubMed ID: 11571735
    [Abstract] [Full Text] [Related]

  • 17. Phase II trial of induction gemcitabine and carboplatin followed by conformal thoracic radiation to 74 Gy with weekly paclitaxel and carboplatin in unresectable stage III non-small cell lung cancer.
    Bepler G, Dilling TJ, Wagner H, Hazelton T, Williams C, Chen DT, Greenberg H, Walsh F, Simon G, Tanvetyanon T, Chiappori A, Haura E, Stevens C.
    J Thorac Oncol; 2011 Mar 01; 6(3):553-8. PubMed ID: 21289520
    [Abstract] [Full Text] [Related]

  • 18. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial.
    Pallarés C, Capdevila J, Paredes A, Farré N, Ciria JP, Membrive I, Basterrechea L, Gomez-Segura G, Barnadas A.
    Lung Cancer; 2007 Nov 01; 58(2):238-45. PubMed ID: 17658655
    [Abstract] [Full Text] [Related]

  • 19. [Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer].
    Wang WH, Bao Y, Chen M, Zhang L, Li KX, Xu GC, Deng XW, Lu TX, Cui NJ.
    Ai Zheng; 2006 Oct 01; 25(10):1279-83. PubMed ID: 17059776
    [Abstract] [Full Text] [Related]

  • 20. Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
    Choong NW, Vokes EE, Haraf DJ, Tothy PK, Ferguson MK, Kasza K, Rudin CM, Hoffman PC, Krauss SA, Szeto L, Mauer AM.
    J Thorac Oncol; 2008 Jan 01; 3(1):59-67. PubMed ID: 18166842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.